Christopher J A Duncan Selected Research

Christopher J A Duncan Research Topics

Disease

24	Infections 10/2023 - 01/2011
14	COVID-19 09/2023 - 01/2021
13	Malaria 01/2017 - 01/2011
4	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2013 - 12/2011
3	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 10/2022 - 01/2020
3	Human Influenza (Influenza) 01/2020 - 07/2012
2	Reinfection 10/2023 - 01/2022
2	Breakthrough Infections 09/2023 - 01/2022
2	VEXAS syndrome 12/2022 - 01/2022
2	Dyspnea (Shortness of Breath) 10/2021 - 01/2021
2	Ageusia (Hypogeusia) 10/2021 - 01/2021
2	Anosmia 10/2021 - 01/2021
2	Cough 10/2021 - 01/2021
2	Fever (Fevers) 10/2021 - 01/2021
2	Encephalitis (Encephalitis, Rasmussen) 01/2019 - 09/2015
2	Virus Diseases (Viral Diseases) 01/2019 - 09/2013
2	Parasitemia 01/2014 - 07/2013
2	Endocarditis 07/2013 - 06/2012
2	Communicable Diseases (Infectious Diseases) 01/2013 - 09/2011
1	Necrotizing Fasciitis 04/2024
1	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2023
1	Zika Virus Infection 01/2022
1	Sudden Infant Death (SID) 01/2022
1	Inflammation (Inflammations) 12/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2021
1	Chickenpox 01/2020
1	Viral Encephalitis 01/2019
1	Chronic Renal Insufficiency 09/2018
1	Acute Kidney Injury (Acute Renal Failure) 09/2018
1	Mumps 09/2015
1	Rubella (German Measles) 09/2015
1	Measles 09/2015
1	Vaccinia 11/2014
1	Drug-Related Side Effects and Adverse Reactions 07/2013
1	Renal Insufficiency (Renal Failure) 07/2013

Drug/Important Bio-Agent (IBA)

25	VaccinesIBA 12/2023 - 01/2011
10	AntigensIBA 01/2023 - 12/2011
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2011
5	AntibodiesIBA 09/2023 - 06/2012
5	Antiviral Agents (Antivirals)IBA 12/2022 - 07/2012
5	Merozoite Surface Protein 1 (MSA1)IBA 04/2014 - 12/2011
4	Interferon Type IIBA 04/2024 - 01/2022
4	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 04/2014 - 06/2012
4	Malaria VaccinesIBA 07/2013 - 01/2012
3	N-(2-cyanoethylene)urea (BA 1)IBA 10/2023 - 01/2023
3	BNT162 VaccineIBA 10/2023 - 01/2022
3	Immunoglobulin G (IgG)IBA 09/2023 - 01/2022
3	Neutralizing AntibodiesIBA 01/2023 - 12/2013
3	mRNA VaccinesIBA 01/2023 - 01/2022
3	ChAdOx1 nCoV-19IBA 10/2021 - 01/2021
3	Nucleic AcidsIBA 10/2021 - 01/2021
3	ThrombospondinsIBA 01/2017 - 01/2013
3	Glycoproteins (Glycoprotein)IBA 02/2014 - 09/2013
2	N-methyl-valyl-amiclenomycin (BA 2)IBA 10/2023 - 01/2023
2	Peptides (Polypeptides)IBA 09/2023 - 02/2013
2	Messenger RNA (mRNA)IBA 01/2023 - 01/2022
2	InterferonsIBA 12/2022 - 01/2022
2	CytokinesIBA 01/2022 - 01/2019
2	EpitopesIBA 01/2017 - 01/2013
1	InflammasomesIBA 04/2024
1	mRNA-1345 respiratory syncytial virus vaccineIBA 12/2023
1	Immunoglobulins (Immunoglobulin)IBA 10/2023
1	Combined VaccinesIBA 10/2023
1	Interferon-gamma (Interferon, gamma)IBA 09/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2023
1	2019-nCoV Vaccine mRNA-1273IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 12/2022
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 10/2022
1	STAT2 Transcription FactorIBA 10/2022
1	Codon (Codons)IBA 01/2022
1	EnzymesIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Ubiquitin-Activating Enzymes (Ubiquitin-Activating Enzyme)IBA 01/2022
1	NucleotidesIBA 01/2022
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Monoclonal AntibodiesIBA 12/2021
1	casirivimab and imdevimab drug combinationIBA 12/2021
1	ibrutinibIBA 12/2021
1	remdesivirIBA 12/2021
1	MenACWYIBA 10/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Antigen Receptors (Antigen Receptor)IBA 01/2021
1	ProteomeIBA 01/2021
1	Viral VaccinesIBA 01/2020
1	Acyclovir (Aciclovir)FDA LinkGeneric 09/2018
1	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 09/2015
1	Virus ReceptorsIBA 12/2014
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2014
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 02/2014
1	LuciferasesIBA 09/2013
1	TeicoplaninIBA 07/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2013
1	LigandsIBA 02/2013

Therapy/Procedure

4	Therapeutics 01/2022 - 07/2013
1	Stem Cell Transplantation 12/2022
1	Transplantation 12/2022
1	Renal Dialysis (Hemodialysis) 01/2022
1	Immunotherapy 12/2021
1	Patient Readmission 07/2013